Kyntra Bio amends revenue interest deal with Project Phoebus
Kyntra Bio amended its revenue interest deal with NQ Project Phoebus, cutting the cap to $65M and paying $42.6M.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.